Dysfunctional HDL and atherosclerotic cardiovascular disease (Q38577283)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2015

Language	Label	Description	Also known as
English	Dysfunctional HDL and atherosclerotic cardiovascular disease	scientific article published on September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

Dysfunctional HDL and atherosclerotic cardiovascular disease (English)

1 reference

Europe PubMed Central

4 September 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Robert S Rosenson

1

1 reference

Europe PubMed Central

4 September 2017

H Bryan Brewer

2

1 reference

Europe PubMed Central

4 September 2017

Benjamin J Ansell

3

1 reference

Europe PubMed Central

4 September 2017

Philip Barter

4

1 reference

Europe PubMed Central

4 September 2017

M John Chapman

5

1 reference

Europe PubMed Central

4 September 2017

Jay W Heinecke

6

1 reference

Europe PubMed Central

4 September 2017

Anatol Kontush

7

1 reference

Europe PubMed Central

4 September 2017

Alan R Tall

8

1 reference

Europe PubMed Central

4 September 2017

Nancy R Webb

9

1 reference

Europe PubMed Central

4 September 2017

language of work or name

0 references

publication date

1 September 2015

1 reference

Europe PubMed Central

4 September 2017

Nature Reviews Cardiology

1 reference

Europe PubMed Central

4 September 2017

13

1 reference

Europe PubMed Central

4 September 2017

1

1 reference

Europe PubMed Central

4 September 2017

48-60

1 reference

Europe PubMed Central

4 September 2017

HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

An abundant dysfunctional apolipoprotein A1 in human atheroma

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

HDL cholesterol efflux capacity and incident cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Biological, clinical and population relevance of 95 loci for blood lipids

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Discovery and refinement of loci associated with lipid levels

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Common variants associated with plasma triglycerides and risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Mendelian randomization of blood lipids for coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Large-scale association analysis identifies new risk loci for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

ATP-binding cassette transporters, atherosclerosis, and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

High-density lipoprotein function, dysfunction, and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

The HDL proteome in acute coronary syndromes shifts to an inflammatory profile

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Inflammation impairs reverse cholesterol transport in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Disorders in high-density metabolism with insulin resistance and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Why is HDL functionally deficient in type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

C-Reactive protein, serum amyloid A protein, and coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Reduction of cold ischemia-reperfusion injury by graft-expressing clusterin in heart transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Associations among smoking status, lifestyle and lipoprotein subclasses

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of extended-release niacin with laropiprant in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Safety of anacetrapib in patients with or at high risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

21 January 2018

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Mendelian randomisation, lipids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.124

31 March 2020

HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26323267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NRCARDIO.2015.124

1 reference

Europe PubMed Central

4 September 2017

0 references

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38577283&oldid=1767707698"